Ristori Giovanni, Cannoni Stefania, Stazi Maria Antonietta, Vanacore Nicola, Cotichini Rodolfo, Alfò Marco, Pugliatti Maura, Sotgiu Stefano, Solaro Claudio, Bomprezzi Roberto, Di Giovanni Simone, Figà Talamanca Lorenzo, Nisticò Lorenza, Fagnani Corrado, Neale Michael C, Cascino Isabella, Giorgi Gabriele, Battaglia Mario A, Buttinelli Carla, Tosi Roberto, Salvetti Marco
Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome La Sapienza, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Ann Neurol. 2006 Jan;59(1):27-34. doi: 10.1002/ana.20683.
Knowledge about the balance between heritable and nonheritable risk in multiple sclerosis (MS) is based on twin studies in high-prevalence areas. In a study that avoided ascertainment limitations and directly compared continental Italy (medium-prevalence) and Sardinia (high-prevalence), we ascertained 216 pairs from 34,549 patients. This gives a twinning rate of 0.62% among MS patients, significantly less than that of the general population. In continental Italy, probandwise concordance was 14.5% (95% confidence interval, 5.1-23.8) for monozygotic and 4.0% (95% confidence interval, 0.8-7.1) for dizygotic twins. Results in Sardinia resemble those in northern populations but in limited numbers. Monozygotic concordance was 22.2% (95% confidence interval, 0-49.3) probandwise, but no concordant dizygotic pairs were identified. A questionnaire on 80 items possibly related to disease cause was administered to 70 twin pairs, 135 sporadic patients, and 135 healthy volunteers. Variables positively (7) or negatively (2) associated with predisposition and concordance in twins largely overlapped and were mainly linked to infection. If compared with previous studies, our data demonstrate that penetrance in twins appears to correlate with MS prevalence. They highlight the relevance of nonheritable variables in Mediterranean areas. The apparent underrepresentation of MS among Italian twins draws attention to protective factors, shared by twins, that may influence susceptibility.
关于多发性硬化症(MS)中遗传风险和非遗传风险之间平衡的认识,是基于高发病率地区的双胞胎研究得出的。在一项避免了确诊局限性并直接比较意大利大陆地区(中等发病率)和撒丁岛(高发病率)的研究中,我们从34549名患者中确定了216对双胞胎。这使得MS患者中的双胞胎出生率为0.62%,显著低于普通人群。在意大利大陆地区,同卵双胞胎的先证者一致率为14.5%(95%置信区间,5.1 - 23.8),异卵双胞胎为4.0%(95%置信区间,0.8 - 7.1)。撒丁岛的结果与北方人群的结果相似,但数量有限。同卵双胞胎的先证者一致率为22.2%(95%置信区间,0 - 49.3),但未发现一致的异卵双胞胎对。我们向70对双胞胎、135名单发患者和135名健康志愿者发放了一份关于80个可能与疾病病因相关项目的问卷。与双胞胎易感性和一致性呈正相关(7个)或负相关(2个)的变量在很大程度上重叠,且主要与感染有关。与之前的研究相比,我们的数据表明双胞胎中的外显率似乎与MS患病率相关。这些数据突出了地中海地区非遗传变量的相关性。意大利双胞胎中MS明显较少这一现象,让人们注意到双胞胎共有的可能影响易感性的保护因素。